IBIO
IBIO
NASDAQ · Biotechnology

Ibio Inc

$1.41
+0.02 (+1.44%)
As of Aug 8, 10:46 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.87M
Net Income
-85,723,915
Gross Margin
38.4%
Profit Margin
-4,594.3%
Rev Growth
-40.3%
D/E Ratio
0.91
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 38.4% 38.4% 65.3% 65.3%
Operating Margin -4,650.5% -4,185.4% -16.4% -13.7%
Profit Margin -4,594.3% -4,364.5% -16.3% -13.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.87M 3.13M 19.24M 18.65M
Gross Profit 716.5K 1.20M 12.56M 12.17M
Operating Income -86,773,912 -130,814,942 -3,161,331 -2,555,901
Net Income -85,723,915 -129,232,032 -3,136,016 -2,526,921
Gross Margin 38.4% 38.4% 65.3% 65.3%
Operating Margin -4,650.5% -4,185.4% -16.4% -13.7%
Profit Margin -4,594.3% -4,364.5% -16.3% -13.6%
Rev Growth -40.3% -40.3% -5.9% +5.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 16.44M 16.44M 23.44M 21.95M
Total Equity 18.09M 18.09M 30.82M 33.89M
D/E Ratio 0.91 0.91 0.76 0.65
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -83,250,733 -132,476,040 -4,591,050 -4,236,243
Free Cash Flow -2,958,449 -2,128,422